Sumatriptan inhibits the release of CGRP and substance P from the rat spinal cord

被引:62
作者
Arvieu, L
Mauborgne, A
Bourgoin, S
Oliver, C
Feltz, P
Hamon, M
Cesselin, F
机构
[1] UNIV PARIS 06,INSERM U288,F-75634 PARIS 13,FRANCE
[2] FAC MED NORD,INSERM U297,F-13326 MARSEILLE 15,FRANCE
[3] UNIV STRASBOURG 1,CNRS URA 1446,F-67084 STRASBOURG,FRANCE
关键词
sumatriptan; substance P; calcitonin generated peptide; in vitro release; dorsal spinal cord;
D O I
10.1097/00001756-199608120-00023
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
THE possible presynaptic action of the anti-migraine drug sumatriptan on primary afferent fibres containing substance P and/or calcitonin gene-related peptide was investigated on superfused rat horizontal spinal cord slices with attached dorsal roots. Electrical stimulation of dorsal roots triggered a significant overflow of both peptides; this could be reduced by sumatriptan in a concentration-dependent manner. As expected from the involvement of 5-HT1B/(1D beta) receptors, methiothepin, (-)tertatolol and GR 127,935, but not WAY 100,635, prevented the inhibitory effect of sumatriptan. These data support the idea that the anti-migraine action of sumatriptan may involve, at least in part, a presynaptic inhibitory control of nociceptive (trigeminovascular) substance P- and/or calcitonin gene-related peptide-containing sensory fibres.
引用
收藏
页码:1973 / 1976
页数:4
相关论文
共 25 条
  • [1] (-)-Pindolol and (+/-)-tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT1A, but also 5-HT1B receptors
    Assie, MB
    Koek, W
    [J]. NEUROPHARMACOLOGY, 1996, 35 (02) : 213 - 222
  • [2] THE MOUSE 5-HYDROXYTRYPTAMINE(1B) RECEPTOR IS LOCALIZED PREDOMINANTLY ON AXON TERMINALS
    BOSCHERT, U
    AMARA, DA
    SEGU, L
    HEN, R
    [J]. NEUROSCIENCE, 1994, 58 (01) : 167 - 182
  • [3] EVIDENCE FOR THE PRESENCE OF 5-HT(1B) RECEPTOR MESSENGER-RNA IN NEURONS OF THE RAT TRIGEMINAL GANGLIA
    BRUINVELS, AT
    LANDWEHRMEYER, B
    MOSKOWITZ, MA
    HOYER, D
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1992, 227 (03): : 357 - 359
  • [4] EVOLUTION OF A NOVEL SERIES OF [(N,N-DIMETHYLAMINO)PROPYL]ANILIDE AND PIPERAZINYLBENZANILIDES AS THE FIRST SELECTIVE 5-HT1D ANTAGONISTS
    CLITHEROW, JW
    SCOPES, DIC
    SKINGLE, M
    JORDAN, CC
    FENIUK, W
    CAMPBELL, IB
    CARTER, MC
    COLLINGTON, EW
    CONNOR, HE
    HIGGINS, GA
    BEATTIE, D
    KELLY, HA
    MITCHELL, WL
    OXFORD, AW
    WADSWORTH, AH
    TYERS, MB
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (15) : 2253 - 2257
  • [5] IN-SITU HYBRIDIZATION EVIDENCE FOR THE SYNTHESIS OF 5-HT1B RECEPTOR IN SEROTONINERGIC NEURONS OF ANTERIOR RAPHE NUCLEI IN THE RAT-BRAIN
    DOUCET, E
    POHL, M
    FATTACCINI, CM
    ADRIEN, J
    ELMESTIKAWY, S
    HAMON, M
    [J]. SYNAPSE, 1995, 19 (01) : 18 - 28
  • [6] HETEROGENEOUS EFFECTS OF SEROTONIN IN THE DORSAL HORN OF RAT - THE INVOLVEMENT OF 5-HT1-RECEPTOR SUBTYPES
    ELYASSIR, N
    FLEETWOODWALKER, SM
    MITCHELL, R
    [J]. BRAIN RESEARCH, 1988, 456 (01) : 147 - 158
  • [7] Fletcher A, 1996, BEHAV BRAIN RES, V73, P337
  • [8] THE TRIGEMINOVASCULAR SYSTEM AND MIGRAINE - STUDIES CHARACTERIZING CEREBROVASCULAR AND NEUROPEPTIDE CHANGES SEEN IN HUMANS AND CATS
    GOADSBY, PJ
    EDVINSSON, L
    [J]. ANNALS OF NEUROLOGY, 1993, 33 (01) : 48 - 56
  • [9] HAMEL E, 1993, MOL PHARMACOL, V44, P242
  • [10] SPECIES-DIFFERENCES IN THE PHARMACOLOGY OF TERMINAL 5-HT AUTORECEPTORS IN MAMMALIAN BRAIN
    HOYER, D
    MIDDLEMISS, DN
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (04) : 130 - 132